the handling of medicinal products and medical devices (therapeutic products);
b.
narcotics as defined in the Narcotics Act of 3 October 19514, insofar as they are used as therapeutic products;
c.
therapeutic treatments, such as gene therapy, insofar as they directly relate to therapeutic products; the Federal Council may enact provisions specific to this subject.
2 The Federal Council may completely or partially exempt medical devices intended for use on animals or in veterinary diagnostics from the scope of this Act.
3 It may make subject to this Act certain products without an intended medical purpose which are comparable to medical devices in terms of functioning and risks profile.5
3 Amended by No I of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).